SGI US Large Cap Equity I holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
SGI U.S. Large Cap Equity Fund Class I SILVX
- NAV / 1-Day Return 19.60 / +0.20 %
- Total Assets 195.2M
-
Adj. Expense Ratio
0.980%
- Expense Ratio 0.980%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Blend
- Investment Style Large Value
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.59%
- Turnover 171%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:45 AM GMT+0
Morningstar’s Analysis SILVX
Will SILVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Regeneron Pharmaceuticals Inc | 3.30 | 6M | Healthcare |
Micron Technology Inc | 3.18 | 6M | Technology |
Mastercard Inc Class A | 3.17 | 6M | Financial Services |
Progressive Corp | 3.13 | 6M | Financial Services |
Costco Wholesale Corp | 3.02 | 5M | Consumer Defensive |
Newmont Corp | 2.99 | 5M | Basic Materials |
NVIDIA Corp | 2.95 | 5M | Technology |
PepsiCo Inc | 2.89 | 5M | Consumer Defensive |
Automatic Data Processing Inc | 2.85 | 5M | Technology |
Colgate-Palmolive Co | 2.72 | 5M | Consumer Defensive |